Embolizing sclerosing hydrogel
US9731043B2 · kind B2 · utility
6Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 11, 2014 |
| Grant date | Aug 15, 2017 |
| Priority date | — |
| Expiry date | Oct 23, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A sclerosing embolizing hydrogel comprising from about 0.1% by weight to about 4.0% by weight of chitosan; from about 0.01M to about 1M of hydrochloric acid; from 0% by volume to about 40% by volume of iopamidol; from 0.5% by weight to about 25% by weight of β-glycerophosphate disodium salt; and from about 0.05% by weight to about 4% by weight of sodium tetradecyl sulphate. Also a kit for synthesizing the hydrogel and a method using the hydrogel to treat a vascular defect in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.